WHO ICTRP trial
Insulin-induced microvascular activity in patients with essential hypertension…
NL-OMON31747 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON31747 |
|---|---|
| Public title | Insulin-induced microvascular activity in patients with essential hypertension: a possible role for angiotensin II AT1-receptor blockers-Amendement 26-03-2008. |
| Scientific title | Insulin-induced microvascular activity in patients with essential hypertension: a possible role for angiotensin II AT1-receptor blockers-Amendement 26-03-2008. - AT1-receptor blockade in insulin-induced dilation-Amendement 26-03-08 |
| Primary sponsor | Academisch Ziekenhuis Maastricht |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | The Netherlands |
| Conditions | high blood pressure hypertension;10018424;10057166;high blood pressure;hypertension |
| Interventions | Main study: Hypertensive subjects will be asked to discontinue the intake of antihypertensive medi-cation three weeks before the start of the study. All subjects will be asked to start a low salt diet (100mmol/day) 7 days prior to the first… |
| Registration date | Apr 17, 2008 |
| Target size | 38 |
| Secondary IDs | 2007-007654-57;NCTTC-1202;NL21113.068.07 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: